Letter: not the end of the role of anti-viral therapy in ulcerative colitis with cytomegalovirus reactivation - authors' reply

被引：0
|
作者：
Delvincourt, M. [1 ]
Sokol, H. [1 ,2 ,3 ]
机构：
[1] Assistance Publ Hopitaux Paris & Paris VI Univ, St Antoine Hosp, Dept Gastroenterol, Paris, France
[2] Univ Paris 06, Laboratoire INSERM U1057 UMR CNRS 7203, Paris, France
[3] Commensal & Probiot Host Interact Lab, UMR 1319 Micalis, Jouy En Josas, France
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 10期
关键词：
INFECTION;
D O I：
10.1111/apt.12722
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1247 / 1248
页数：2
相关论文
共 50 条
  • [1] Letter: mucosal PCR for cytomegalovirus in refractory ulcerative colitis - authors' reply
    Chaparro, M.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (08) : 812 - 812
  • [2] Anti-Viral Therapy is Not Necessarily Indicated in Ulcerative Colitis Patients With Cytomegalovirus Infection Detected by Immunohistochemistry
    Maruyama, Yuriko
    Matsuoka, Katsuyoshi
    Iwao, Yasushi
    Yajima, Tomoharu
    Inoue, Nagamu
    Hisamatsu, Tadakazu
    Sujino, Tomohisa
    Takabayashi, Kaoru
    Yoneno, Kazuaki
    Mikami, Yohei
    Miyoshi, Jun
    Mizuno, Shinta
    Kimura, Kayoko
    Kanai, Takanori
    Ogata, Haruhiko
    Mukai, Makio
    Hibi, Toshifumi
    GASTROENTEROLOGY, 2012, 142 (05) : S363 - S363
  • [3] Letter: comparative efficacy of biological therapy in patients with ulcerative colitis - authors' reply
    Stidham, R. W.
    Lee, T. C. H.
    Higgins, P. D. R.
    Deshpande, A. R.
    Sussman, D. A.
    Singal, A. G.
    Elmunzer, B. J.
    Vijan, S.
    Saini, S. D.
    Waljee, A. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (12) : 1433 - 1434
  • [4] Is cytomegalovirus really a cause of resistance to steroids in ulcerative colitis? The authors reply
    Takahashi, Y
    Tange, T
    DISEASES OF THE COLON & RECTUM, 2005, 48 (01) : 174 - 175
  • [5] Letter: direct-acting anti-viral (DAA) therapy needs strong safety and efficacy check-authors' reply
    Singer, A. W.
    Reddy, K. R.
    Telep, L. E.
    Osinusi, A. O.
    Brainard, D. M.
    Buti, M.
    Chokkalingam, A. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (02) : 235 - 236
  • [6] Reply: Careful Assessment Is Needed in Patients with Ulcerative Colitis with Evidence of Cytomegalovirus Reactivation
    Kim, You Sun
    Kim, Joo Sung
    GUT AND LIVER, 2015, 9 (02) : 254 - 255
  • [7] Letter: biological drugs for inducing remission in ulcerative colitis - authors' reply
    Stidham, R. W.
    Lee, T. C. H.
    Higgins, P. D. R.
    Deshpande, A. R.
    Sussman, D. A.
    Singal, A. G.
    Elmunzer, B. J.
    Saini, S. D.
    Vijan, S.
    Waljee, A. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1244 - 1244
  • [8] Letter: which patient profile for tacrolimus in ulcerative colitis? Authors' reply
    Yamamoto, T.
    Shimoyama, T.
    Umegae, S.
    Matsumoto, K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (11) : 1243 - 1243
  • [9] Letter: a case supporting the use of rescue infliximab therapy for fulminant ulcerative colitis in pregnancy - authors' reply
    Schulze, H.
    Esters, P.
    Dignass, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (03) : 326 - 326
  • [10] Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma - authors' reply
    Gupta, A.
    Loftus, E. V., Jr.
    De Felice, K. M.
    Khanna, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (01) : 176 - 176
12345